Ibrutinib for MCL Just as Effective in the NHS as in Trials Ibrutinib for MCL Just as Effective in the NHS as in Trials

The impressive clinical response to ibrutinib seen in mantle cell lymphoma clinical trials can be achieved in the National Health Service, say UK clinicians, although progression rates remain high.Medscape News UK
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news